The Use of Epidermal Growth Factor Receptor Monoclonal Antibodies in Squamous Cell Carcinoma of the Head and Neck

Targeting of the EGF receptor (EGFR) has become a standard of care in several tumor types. In squamous cell carcinoma of the head and neck, monoclonal antibodies directed against EGFR have become a regular component of therapy for curative as well as palliative treatment strategies. These agents hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Jeffery S., Colevas, A. Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488396/
https://www.ncbi.nlm.nih.gov/pubmed/23150825
http://dx.doi.org/10.1155/2012/761518

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488396/
https://www.ncbi.nlm.nih.gov/pubmed/23150825
http://dx.doi.org/10.1155/2012/761518

Ejemplares similares